What is the recommended administration protocol for thiamine (Vitamin B1)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Thiamine Administration Protocol

For thiamine administration, the recommended protocol depends on the clinical situation, with intravenous administration of 100-300 mg/day recommended for acute deficiency and hospitalized patients, while oral administration of 10 mg/day for one week followed by 3-5 mg/day for at least 6 weeks is appropriate for mild deficiency. 1, 2

Route of Administration

  • For suspected chronic deficiency without acute disease, the oral route is adequate 1, 2
  • For acute disease or suspected inadequate intake, the IV route should be used 1, 2
  • For patients with alcohol-related gastritis, the IV route is preferred due to poor absorption 2
  • When administering IV thiamine, be aware that serious hypersensitivity/anaphylactic reactions can occur, especially after repeated administration 3

Dosage by Clinical Situation

Mild/Preventive Cases

  • Mild deficiency (outpatients): 10 mg/day orally for one week, followed by 3-5 mg/daily for at least 6 weeks 1, 2
  • Chronic diuretic therapy: 50 mg/day orally 1, 2
  • Maintenance dose after proven deficiency: 50-100 mg/day orally 1, 2

Moderate Risk Cases

  • At risk for deficiency: 100 mg, 3 times a day, IV 1
  • Continuous renal replacement therapy: 100 mg/day 1, 2

High Risk/Acute Cases

  • Hospitalized patients/critical illness: 100-300 mg/day IV 1, 2
  • Emergency/intensive care patients: 100-300 mg/day IV for 3-4 days from admission 1, 2
  • High suspicion or proven deficiency: 200 mg, 3 times a day, IV 1
  • Prolonged vomiting or dysphagia: 200-300 mg thiamine daily plus vitamin B co strong 1-2 tablets three times daily 1

Severe Cases

  • Encephalopathy of uncertain etiology (including Wernicke encephalopathy): 500 mg, 3 times a day, IV 1, 2, 4
  • Refeeding syndrome: 300 mg IV before initiating nutrition therapy, then 200-300 mg IV daily for at least 3 more days 1, 2

Important Safety Considerations

  • A skin test should be performed on patients suspected of drug allergies or previous reactions to thiamine 3
  • If hypersensitivity is suspected, administer one-hundredth of the dose intradermally and observe for 30 minutes before giving full dose 3
  • Be prepared to treat anaphylactic reactions with epinephrine, oxygen, vasopressors, steroids, and antihistamines 3
  • Thiamine should be administered before glucose-containing IV fluids to avoid precipitating acute thiamine deficiency 2
  • The product contains aluminum that may reach toxic levels with prolonged parenteral administration if kidney function is impaired 3

Duration of Treatment

  • For mild deficiency: at least 6 weeks 2
  • For Wernicke encephalopathy: high-dose IV thiamine (500 mg three times daily) for 3-5 days, followed by 250 mg IV daily for at least 3-5 additional days 5
  • For alcoholic liver disease: 100-300 mg/day for 2-3 months 2

Monitoring

  • Thiamine status should be determined by measuring RBC or whole blood thiamine diphosphate (ThDP) 1, 2
  • Monitoring is recommended in patients with suspected deficiency and cardiomyopathy, prolonged diuretic treatment, prolonged medical nutrition, post-bariatric surgery, refeeding syndrome, or encephalopathy 1, 2

Toxicity

  • No upper limit for toxicity has been established; excess thiamine is excreted in urine 1, 2
  • High IV doses rarely cause anaphylaxis; doses >400 mg may induce nausea, anorexia, and mild ataxia 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Thiamine Supplementation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.